Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Sep 9, 2016 (10 years ago)

Cytotec (misoprostol)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Cytotec (misoprostol) Tablets, 200 mcg, 100 Tablets blister pack (10X10), For in-institution use only, Rx only, Distributed by G.D. Searle, Division of Pfizer, Inc., NY, NY --- NDC 0025-1461-34

Affected NDC 0025-1461-34

Compare with the code on your package — it is the most precise check available.

Drug: Misoprostol

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Cytotec
misoprostol
NDC 00025-1461
200 ug/1 Tablet
Oral
Pfizer Laboratories Div Pfizer Inc Rx
Recalling firm
Pfizer Inc.
NDC code
0025-1461-34
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0424-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Misoprostol recalls

See all
Class II · Moderate risk

Misoprostol 1% active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-802-2015

Other recalls by Pfizer Inc.

All 2016 recalls